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Abstract
The goal of this project was the synthesis of 4-substitued coumarins and 2H-chromene-2-thione
derivatives that can be used to inhibit or retard the growth of cancer cells. According to the
American Cancer Society’s 2012 death statistics for prostate cancer, 28,170 men died from
prostate cancer and there was 241,740 (29%) new cases of prostate cancer as well (Society,
2012). Few studies have been conducted on 2H-chromene-2-thiones and their ability to act as
cancer chemopreventive or anticancer agents, therefore, we seek to synthesize a sequence of
coumarins and 2H-chromene-2-thiones via the Von Pechmann reaction. We believe that the 2Hchromene-2-thiones will exhibit better chemopreventive activity then the analogous coumarins
because of the presence of the softer sulfur atom. The syntheses of the coumarin derivatives in
this study were accomplished using green chemistry. The indium chloride catalyzed Von
Pechmann condensation required no solvent and formed coumarins efficiently. Upon
synthesizing coumarins, they were converted into their 2H-chromene-2-thione analogs using
Lawesson’s reagent. Percent yields of the coumarin derivatives range from 40% to 80%. The 2Hchromene-2-thione percent yields range from 11% to 61%.
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CHAPTER 1
Introduction
1.1 Cancer Statistics
According to the American Cancer Society, the number of new cases of cancer in 2011
was an estimated 1,596,670 (Society, 2011). This is an increase of 67,110 from 2010, and an
increase of 117,320 from 2009. American Cancer Society’s death statistics for Cancer shows
that more than half a million individuals died from Cancer in 2011 (571,950) which is more than
1500 persons a day (Society, 2011). This is an overall increase of 12,070 deaths from Cancer in
the past three years, (569,490 in 2010, and 562,340 in 2009)(Society, 2009, 2010).
1.1.1 Mechanism of cancer. Carcinogens are compounds that initiate tumor
development and during the initiation phase (the first stage of carcinogenesis), the carcinogen
interacts with DNA in the cell. Ultra-violet radiation, viruses, television waves, and microwaves;
even down to the foods that we eat, and how they are prepared can allow for the development of
cancerous tumors. (Alomirah et al., 2011) Carcinogenesis has four stages: Initiation, promotion,
progression, and finally malignant conversion (Tannock, 2005).

Figure 1. Mechanism of cancer (Tannock, 2005).
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Figure one illustrates the mechanism of how cancer develops and causes damage to
normal cells. During each stage of cancer, there is a genetic change that takes place. A
carcinogen damages the DNA sequencing and creates a break in the DNA strand (Tannock,
2005). However, during initiation the mechanisms to allow cellular repair and apoptosis
promotion are still functioning. During the promotion phase, in the cell cycle phase (M phase)
the damaged genome is copied to a new daughter cell (Tannock, 2005). When an individual has
prolonged exposure to the carcinogen, kinases (proteins) called promoters, are overexpressed.
This increase in expression levels promotes the formation of tumors/lesions that are benign at
this stage. Because the cancerous tumors have yet to progress to the final stage of carcinogenesis,
apoptosis of the cell (programmed cell death) can occur and damage that occurred at this stage
can be overturned. From the repeating of the first two stages, initiation and promotion, there is
transformation of the tumor from benign to neoplastic. This is said to be progression, the third
stage in carcinogenesis (Tannock, 2005). Malignant conversion is the final stage of cancer. In
this stage, the cells divide and grow uncontrollably because of expression of the neoplastic
phenotype. This process will allow for the development of malignant tumors (Tannock, 2005).
1.1.1.1 Tumor suppressor genes and oncogenes. During carcinogenesis oncogenes and
tumor suppressor genes are altered. The difference between an oncogene and a tumor suppressor
gene is that an oncogene is mutational activation of proteins that normally promote cell
proliferation (Weinberg, 2007). A tumor suppressor gene is mutational inactivation of proteins
that normally inhibits cell proliferation. During the cell cycle, if a cell is found to have any
damage, the tumor suppressor genes normally repair the damage. However, if the damage is
beyond repair the tumor suppressor genes will signal for the cell to undergo apoptosis. If there
are mutations in the tumor suppressor genes, the signaling of the cells to undergo apoptosis will
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not occur and the cells will continue to proliferate. An oncogene promotes cancer growth and
transforms cells from a normal state to a cancerous state. Oncogenes are different from tumor
suppressor genes with the loss of function such as unregulated activation of the oncogenes to
promote a cell to proliferate even though it has mutations within itself (Weinberg, 2007). With
the oncogene’s gain of a function it can initiate cancer development. An example of a protooncogene that can undergo transformation into an oncogene is Src. Src is a kinase that
phosphorylates substrates. When there is a mutation of Src it becomes v-src (viral-Src) and may
cause proliferation of cells (Weinberg, 2007).
Tumor suppressors are defensive genes that restrict the growth of tumors. Cancer can
develop if the tumor suppressor loses its function. An example of a tumor suppressor is
Adenomatous Polyposis Coli (APC) and p53. Tumor suppressor gene, p53 serves as the
“security” of the cell as it keeps everything in order. If p53 receives information about genetic
damage or a metabolic disorder within a cell it may delay the cell going into the next phase of
the cell cycle (Weinberg, 2007). If the damage is beyond repair, p53 can signal for the cell to
undergo apoptosis. However if there is a mutation within p53 this disables the genes ability to
function in its normal capacity. A mutation in p53 can bring about prostate cancer in men, and a
mutation in APC can bring about colon cancer in 70% of sporadic cases of the disease
(Weinberg, 2007). In terms of sporadic cases of cancer development, according to the multi-hit
theory of cancer development Scientist Alfred Knudson hypothesized that cancer is brought
about from a “series” of mutations and not a single mutation (Weinberg, 2007). In 1987,
Knudson conducted a study on children with retinoblastoma to prove his hypothesis to be
correct. Knudson’s observations showed that there were two distinct categories of patients,
patients who had family members with retinoblastoma (familial form), and the other category is
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those who did not have a family history of retinoblastoma (sporadic form). Those who developed
the sporadic form of retinoblastoma only developed a tumor in one eye. But the patients who
developed the familial form developed a tumor in both eyes. If an individual has mutations in a
specific gene, then this is probable cause for tumor development. Using the retinoblastoma case
as an example, an individual had to inherit a mutated gene. Hence, mutations in both copies of a
gene are needed for the retinoblastoma gene to initiate tumor development. However in the
sporadic form, the tumor develops over a period of time, because only one gene mutation is
inherited in the familial form. The multi-hit theory is also inclusive of the fact that cancer
development is driven by not only the deactivation of tumor suppressor genes, but also the
activation of proto-oncogenes.
1.1.1.1.1 The application of cancer chemoprevention. Cancer chemoprevention is the use
of chemical compounds or dietary components either to protect against the initiation of
carcinogenesis or stop the growth of a cancerous tumor. Figure 2 provides a schematic of the
biological approach to preventing cancer. As previously stated in the multi hit theory of cancer
development, before a carcinoma develops, there are a series of events that leads to this
development. This development can be caused by abnormalities in several biological
mechanisms. During carcinogenesis, there are several pathways that can lead to cancer. Figure 2
illustrates three of the numerous pathways to cancer formation, which are antiapoptosis, growth
factors, and proangiogenesis. Ras, an oncogene, and Rb, a tumor suppressor gene, when altered
can bring about cancer. EGF, VEGF, and BFGF are growth factors. When there is an imbalance
in these growth factors, this mutation can accelerate the transformation of a normal cell into a
cancerous cell (Tsao, Kim, & Hong, 2004). Therefore, cancer chemoprevention can be applied to
inhibit or halt the abnormal signaling of tumor suppressor/oncogenes, growth factors as well as
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other biological factors such as deregulation of enzymes (telomerase activity) and pathways
(cyclooxygenase pathway) (Tsao et al., 2004). Figure 2 shows three different pathways of
carcinogenesis and without treatment these pathways can lead to cancer. Figure 2 also shows the
application of antiapoptotic and antiangiogenic compounds such as Farnesyltransferase inhibitors
(to inhibit oncogene Ras activity), Retinoids (to stop the abnormal expression of tumor
suppressor gene Rb), EGF, VGEF and COX-2 growth factor inhibitors to halt the formation of
new blood vessels.

Figure 2. How cancer chemoprevention works.
Cancer chemoprevention is of importance to the field of cancer therapy and treatment
because application of compounds found within nature and those that are similar in structure to
natural products would be an appropriate alternative to conventional medicine used today for the
treatment of cancer. Coumarin derivatives have been widely utilized in the synthesis of cancer
chemoprevenetive agents (Subhas Bose, Rudradas, & Hari Babu, 2002). Some studies suggest
that naturally occurring coumarins that are taken by mouth have the possibility to induce phase I
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and II enzymes within the body (Kleiner et al., 2001). These coumarins can also induce GST
(glutathione s-transferase) activity, a phase II enzyme. It was found that linear furanocoumarins
when administered showed a lack in the inhibition of pentoxyresorufin ortho-dealkylase (PROD)
activity in the liver of lab mice. However, isopimpinellin, a chemical isolated from linear
furanocoumarins increased GST activity in the forestomach and the small intestine of the lab
mice (Kleiner et al., 2001). Results from this study also suggested that isopimpinellin, induced
phase I and II enzymes in several tissues within the body and some that are specific for
polycyclic aromatic hydrocarbons (PAH) carcinogenesis (Kleiner et al., 2001). Thus coumarins
are of significance in cancer chemoprevention and phase I and II enzyme induction.
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CHAPTER 2
Literature Review
2.1 Naturally Occurring Coumarins

Figure 3. Structures of some naturally occurring coumarins.
2.1.1 Coumarins in foods. Coumarin, an oxygen heterocycle, has been found naturally
in fruits and vegetables that we eat (Singh, Devi, Thokchom, & Sharma, 2010). Figure 3 shows
the structures of some of the numerous coumarin derivatives that are found naturally. Coumarin,
chemical name 1,2-benzopyrone are consumed by humans on a regular basis. In celery, the pulp
and rind of limes is where furanocoumarin isopimpinellin is found. The coumarin derivative is
found in fruits such as strawberries, grapefruits, apricots and cherries also. Cumin (used to make
curry powder), cinnamon, parsnips, are used as flavorings in food preparation, are some of the
numerous plant based foods that naturally contain coumarins (Kleiner et al., 2001). Coriander,
cilantro in its leaf form, contains coumarin derivative 7-methylcoumarin.
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2.1.2 Coumarins in plants. Coumarins are also found naturally in plants as well. The
plant sweet clover has a high content of coumarin which is responsible for the sweet aroma of
the plant. Lavender, Tonka beans, and Licorice are other plants with high coumarin content as
well (Goel, Prasad, Parmar, Ghosh, & Saini, 2007). Herniaria glabra, common name rupturewort,
which is believed to have diuretic properties, contains the coumarin derivative 7methoxycoumarin (Santamour Jr & Riedel, 1994). Not only are coumarins founds naturally in
plants and foods, they possess medicinal properties as well. Some derivatives contain antioxidant, diuretic, anti-bacterial, and anti-hypertensive properties, while others have anti-HIV,
and anti-tumor properties (Goel et al., 2007). From these foods naturally containing coumarins,
they can be eaten to possibly reduce or minimize one’s development of cancer.
2.1.3 Coumarins for medicinal use. From the molding of the sweet clover plant by
fungi such as penicillium, the coumarin derivative dicoumarol is formed (Kresge, Simoni, &
Hill, 2005). In the 1920s, when cattle would eat the molded sweet clover, it caused them to bleed
excessively due to dicoumarol’s anti-coagulant properties (Antonella Tonna, 2004). In the 1940s,
dicoumarol was used as an anti-coagulant drug to treat individuals with thrombosis which is the
formation of blood clots in blood vessels that could potentially migrate to other parts of the body
(Antonella Tonna, 2004). In 1954 dicoumarol was officially discontinued, as Warfarin (another
coumarin derivative) was approved for use as an anti-coagulant drug which is currently still
administered to treat thrombosis.
2.2 Synthesis of Coumarin Derivatives
As stated previously, coumarin derivatives have been widely utilized in the synthesis of
cancer chemopreventive agents (Subhas Bose et al., 2002).There are numerous routes to
synthesize the coumarin derivative. Scheme 1 illustrates a few synthetic routes to obtain the
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coumarin derivative. Each reaction listed undergoes condensation. The Witting reaction is shown
in reaction 1. The reaction takes place via a one pot synthesis of ethyl bromoacetate and orthohydroxybenzaldehyde in the presence of triphenylphosphine. Triethylamine is used as the base in
this synthesis. The reaction labeled 2 is the Knoevenagel condensation of salicylaldehyde with
various derivatives of ethyl acetoacetate under microwave irradiation.

Scheme 1. Various synthetic routes to obtain coumarin derivatives.
In reaction 1, piperdine is utilized as the base. How the reaction proceeds is deprotonation
from the piperdine allows for enol formation. The enol that is formed reacts with the aldehyde to
have elimination of the aldol to obtain the coumarin molecule (Bogdal, 1998). In 1883, chemists,
Hans Von Pechmann and Duisberg in were the first to synthesize 7-hydroxy-4-methylcoumarin
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(β-methylumbelliferone) via condensation of the phenol and β- keto ester, resorcinol and ethyl
acetoacetate. The Von Pechmann condensation can occur via numerous synthetic routes. The
standard method for synthesizing coumarins via the Von Pechmann route is the reaction of
phenol with ethyl acetoacetate in sulfuric acid. The overall mechanism is carried out under acidic
conditions. Reaction scheme 3, in scheme 1 shows the reaction takes place via the condensation
of Malic acid in the presence of sulfuric acid at 120oC. Formylacetic acid is formed in situ (in
solution). The formylacetic acid reacts with the resorcinol to yield the coumarin derivative.

Scheme 2. General synthesis of 7-hydroxy-4-methyl-2H-chromene-2-thione.
The studies of others have shown that the synthesis of 4-methyl coumarins via the Von
Pechmann reaction proves to be a simple and capable way of carrying out the synthesis. A study
conducted by D. Bose, A. Rudradas and M. Babu utilized Indium (III) chloride as a catalyst for
the Von Pechmann condensation under solvent free conditions. They obtained excellent results
with coumarin derivatives in high percent yields (90% yields or more in most cases) thus proving
Indium Chloride’s effectiveness in catalyzing the reaction (Subhas Bose et al., 2002). From their
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studies and the excellent results they obtained, the Von Pechmann condensation utilizing Indium
Chloride was chosen as the synthetic route to obtain the coumarin derivatives for this research.
Scheme 2 illustrates the synthetic steps taken to obtain the target molecules that are 7hydroxy-4-methyl substituted 2H-chromene-2-thiones. These will be the necessary steps taken to
obtain the target molecule within this research. For this particular study, ethyl acetoacetate was
the β-keto ester of choice. Indium (III) chloride was used as a catalyst in this reaction due to its
proven effectiveness as a Lewis acid catalyst. In this study, eight compounds were synthesized
using various phenols and a β-keto ester.
2.3 Synthesis of 2H-Chromene-2-Thiones

Figure 4. Structure of Lawesson’s reagent.
2.3.1 Lawesson’s reagent. Figure 4 shows the chemical structure of Lawesson’s
Reagent. Lawesson’s Reagent is a potent yet mild thionating agent that has been widely utilized
as it successfully transforms an oxygen atom into its respective thio analog (Z. Wang, 2010). It
has also been used to carry out the transformation of carbon-oxygen single bonds into carbonsulfur single bonds. Lawesson’s Reagent has also been used for the cyclization of compounds
that obtain at the least two oxygen atoms (Z. Wang, 2010). For this particular research 7hydroxy-4-methyl derivatives are obtained for each synthesis due to ethyl acetoacetate being the
β-keto ester of choice for the synthesis of the coumarins, and when converted into the 2Hchromene-2-thione derivative only the oxygen atom will be replaced. Preliminary studies suggest
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that using Lawesson’s reagent to carry out the conversion of 7-hydroxy-4-methyl coumarin to 7hydroxy-4-methyl 2H-chromene-2-thione, is an easy and effective way of doing so (shown in
scheme 1). This is due to the Lawesson’s reagent’s ability to easily substitute the oxygen atom
for a sulfur atom (Levai & Jekoe, 2005).

Scheme 3. General synthesis of 2H-chromene-2-thione.
Table 1
Different Classes of Cancer Chemopreventive Agents

Blocking Agents

Suppressing Agents

Anti-oxidants

Anti-inflammatory

Free Radical
Scavengers

Protease inhibitors

Inducers of Glutathione Stransferase

Protein Kinases

Modifiers of mixed function
oxidases

Ornithine Decarboxylase
Inhibitors of prostaglandin synthesis

2.4 Michael Acceptors
Cancer chemopreventive agents are classified by the mechanism in which they inhibit
carcinogenesis. According to studies conducted by Arnold and Wilkinson et.al, indicates there
are three distinct categories that majority of cancer chemopreventives fall within; those are,
agents that block the reactive metabolites from the target sites of cells, agents that suppress
progression or promotion of neoplasia, and those that prevent metabolic activation of the
carcinogen (Arnold, Wilkinson, Sharma, & Steele, 1995). There are nine classes of
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chemopreventive agents; table 1 lists the nine classes. As seen in the table, some of these agents
within this class are anti-oxidants, free radical scavengers, inducers of glutathione S-transferase,
and anti-inflammatory. Some of the agents could aid in the inhibition of the binding and
metabolism of carcinogens during the initiation phase, while others suppress the promotion
phase of carcinogenesis.

Scheme 4. Michael adduct formation.
Michael acceptors are cancer chemopreventive agents that stop the progression of
carcinogenesis. The mechanism the Michael acceptors begin with a formation of a covalent
adduct of the Michael donor to the Michael acceptor (Dorai & Aggarwal, 2004). Scheme 4
illustrates the formation of the covalent Michael adduct. Biologically native Michael donors are
compounds that are found within the body such as glutathione S-tranferase. We envisage that a
nontoxic xenobiotic such as coumarin derivatives (Michael acceptors) can be introduced into the
body and will begin a cascade of detoxification processes.
Coumarins are well known cancer chemopreventive agents and acts as an excellent
Michael acceptor as it has proven capabilities of suppressing the progression of neoplasia in
human lung adenocarcinoma cells (Goel et al., 2007). This occurs by allowing for the cells to
undergo apoptosis. Figure 3 shows the structure of coumarin and its respective thio analog. As
seen, the structures of the molecules are similar. The only variance is the oxygen atom is
substituted for a sulfur atom. To improve the 1,4-addition, a sulfur atom is substituted at the 2
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position of the coumarin due to the softness of sulfur. Softness in organic chemistry refers to an
atom that has a small oxidation state (charge on the atom) and is strongly polar meaning its
ability to share electrons with other atoms is high. Oxygen is a hard atom which means that it is
smaller than sulfur and in conjunction with being very electronegative these factors are
responsible for its hardness. Sulfur is twice the size of oxygen and very polar which allows
Sulfur to share its electrons with other atoms. By making the substitution, the Michael acceptor
is believed to be better at inhibiting carcinogenesis. Studies by chemists, Kumar and Singh et.al,
proves that 2H-chromene-2-thione derivatives have better cancer chemopreventive activity than
its analogous coumarin derivative. The 2H-chromene-2-thione derivatives studied showed free
radical scavenging and anti-inflammatory properties.

Figure 5. Structure of 2H-chromene-2-one and thione.
2.5 2H-Chromene-2-Thione Derivatives as Chemopreventive Agents
Few studies have been conducted on 2H-chromene-2-thione derivatives and their ability
to act as cancer chemopreventive agents. However, via the research of Sharma, 2H-chromene-2thione have proven to obtain excellent capabilities in being utilized as cancer chemopreventive
compounds due to their potency (Kumar et al., 2005). 2H-chromene-2-thione derivatives and
their ability to inhibit TNF-α induced ICAM-1 expression on human umbilical vein endothelial
cells have been studied (Kumar et al., 2005). TNF-α is tumor necrosis factor a signaling protein
that is responsible for inflammatory response in humans. This is why individuals with chronic
disorders such as asthma, and rheumatoid arthritis experience episodes of inflammation. TNF-α
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is responsible for the expression of Inter Cellular Adhesion Molecule-1 (ICAM-1) which is a
protein expressed by human genes that are typically found in endothelial cells. ICAMs are
molecules that are responsible for cell to cell binding to allow for transmigration of the
leukocytes into the endothelial cells that are located within blood vessels. With the
overexpression of ICAM-1, this can allow for infiltration of leukocytes across the blood vessels
and allow for inflammation to occur. S. Kumar, and B. Singh during their study, concluded that
7,8-dibenzyloxy-4-methyl-2H-chromene-2-thione was superior over the 7,8-dibenzyloxy-4methylcoumarin in the inhibition of TNF-α induced ICAM-1 expression (Kumar et al., 2005).
The structure of the two chemical compounds may be an explanation as to why the 2Hchromene-2-thione worked better than the coumarin (Kumar et al., 2005).
Sulfur is of significance in this research because sulfur is one of the components in
numerous organic compounds that have biological functions within the body. The compounds
that were synthesized in this research will potentially induce enzymes found within the body.
The thio group is a very important component in regards to biological functions. For example,
glutathione, a peptide which contains a sulfur group, is involved in protein and DNA synthesis.
Environmental and drug toxin metabolism and amino acid transports are some of the many
functions of glutathione as well (Trudy McKee, 2011). Glutathione can also be used as a
reducing agent by protection of cells from the vicious effects of oxidation. How this occurs is
glutathione reacts with peroxides which are bi-products of O2 metabolism (Trudy McKee, 2011).
An example of this is, in red blood cells, hydrogen peroxide (H2O2) oxidizes the iron in
hemoglobin to its ferric form Fe+3. From this reaction a product methemoglobin, is produced.
However, methemoglobin cannot attach itself to oxygen, therefore glutathione acts as a reducing
agent by reducing hydrogen peroxide to protect against the formation of methemoglobin (Trudy
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McKee, 2011). Biological important peptides, glutathione, oxytocin, cysteine, and vasopressin
all have intra cellular antioxidant activity, and adulteration of these biothiols can be possible
warning sign of AIDS and various cancers (Kim, Lee, Kwon, & Kim, 2011); hence, the synthesis
of 2H-chromene-2-thione derivatives and determining their potency (their ability to aid the body
in retarding the growth of cancer cells) is of great importance (Maresca et al., 2009).
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CHAPTER 3
Methodology
3.1 Experimental
3.1.1 Materials and methods. For this research, Indium (III) chloride, Lawesson’s
Reagent, Zirconium (IV) Chloride and various Resorcinol derivatives where purchased from
Acros Chemicals. Ethyl acetoacetate was purchased from Sigma-Aldrich. DMSO ampoules
(0.75mL) were purchased from Cambridge Isotope Lab Incorporated and the Ethanol used for
recrystallization was purchased from Fisher. All reagents and solvents were used as purchased.
3.1.2 Characterization of compounds. For characterization purposes, 1H and 13C
Nuclear Magnetic Resonance analysis were obtained using a 300 MHz NMR instrument from
Varian and 400 MHz instrument from Varian used at the North Carolina Agricultural and
Technical State University Joint School of Nanoscience and Nanoengineering. Preparation of the
coumarin samples for NMR analysis was carried out using ampoules of Dimethyl Sulfoxide
(0.75mL) to dissolve the coumarin. Each sample was dissolved with the DMSO and placed into
sample tubes for NMR analysis. 1H and 13C NMR chemical shifts for the coumarin and 2Hchromene-2-thione are expected to vary in the 1H and 13C NMR. This variation will determine if
the coumarin was converted into its thio analog.

Scheme 5. Synthesis of 7-hydroxy-4-methylcoumarin.
3.2 Synthesis of Coumarin Derivatives
3.2.1 Synthesis of 7-hydroxy-4-methylcoumarin (3). As shown in scheme 4, the
synthesis of 7-hydroxy-4-methylcoumarin took place via a mixture of 1.103g of Resorcinol (1.0
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mmol) and 1.304g of ethyl acetoacetate (1mmol) that refluxed for 1hr. in the presence of Indium
Chloride as the catalyst. After the reflux, the reaction mixture was cooled to room temperature,
and then washed with cold deionized water. After the water wash, the reaction mixture was
filtered and re-crystallized with hot EtOH. After recrystallization, the product was filtered and
washed with EtOH. In the final step, the product was placed into a storage vial and onto the high
vacuum line for further drying overnight. Beige powder; 80% yield; m.p. 184oC (Sharma,
Janardhan Reddy, Sree Lakshmi, & Radha Krishna, 2005) 1H NMR (301 MHz, DMSO-d6) δ
10.53 (s, 1H), 7.58 (d, J = 8.7 Hz, 1H), 6.79 (d, J = 11.0 Hz, 1H), 6.69 (s, 1H), 6.12 (s, 1H), 2.35
(d, J = 1.0 Hz, 3H).
3.2.2 Synthesis of 7-hydroxy-4,8-dimethylcoumarin (4). The synthesis of 7-hydroxy4,8 dimethylcoumarin took place via a mixture of 1.24g of Resorcinol (1.0 mmol) and 1.304g of
Ethyl Aceto Acetate (1.0 mmol) that refluxed for 1hr. white powder; 84% yield; m.p. 253-255oC
(Sharma et al., 2005) 1H NMR (301 MHz, DMSO-d6) δ 10.41 (s, 1H), 7.54 – 7.36 (m, 2H), 6.86
(d, J = 9.4 Hz, 2H), 6.12 (s, 2H), 2.36 (s, 3H), 2.15 (s, 3H). 13C NMR (101 MHz, cd3cn) δ
197.56, 163.24, 157.82, 146.33, 126.05, 115.20, 113.72, 100.36, 55.88, 29.90, 17.18.
3.2.3 Synthesis of 6-chloro-7-hydroxy-4-methylcoumarin (5). The synthesis of 6chloro-7-hydroxy-4-methylcoumarin took place via a mixture of 1.45g of 4-Chloro Resorcinol
(1.0 mmol) and 1.304g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. Brown powder;
8% yield; m.p. 278o-280oC (Chakravarti & Ghosh, 1935) 1H NMR (301 MHz, DMSO-d6) δ
11.40 (s, 1H), 7.75 (s, 1H), 6.88 (s, 1H), 6.20 (s, 1H), 2.37 (s, 3H).
3.2.4 Synthesis of 6-n-dodecyl-7-hydroxy-4-methylcoumarin (6). The synthesis of 7hydroxy-4-methylcoumarin took place via a mixture of 2.784g of 4-n-dodecyl Resorcinol (1.0
mmol) and 1.304g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. Tan crystals; 84.8%
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yield; m.p. 138oC (Kansara & Shah, 1948); 1H NMR (301 MHz, DMSO-d6) δ 10.46 (s, 1H),
7.40 (s, 1H), 6.70 (s, 1H), 6.08 (d, J = 1.3 Hz, 1H), 2.34 (d, J = 1.2 Hz, 3H), 1.51 (p, J = 6.6 Hz,
2H), 1.22 (d, J = 12.1 Hz, 15H), 0.82 (t, J = 6.4 Hz, 3H).
3.2.5 Synthesis of 7,8-dihydroxy-4-methylcoumarin (7). The synthesis of 7,8dihydroxy 4-methylcoumarin took place via a mixture of 1.261g of Pyrogallol (1.0 mmol) and
1.304g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. purple crystals; 46.4% yield; m.p.
241-243oC (Sharma et al., 2005) 1H NMR (301 MHz, DMSO-d6) δ 7.70 (s, 1H), 7.68 (s, 1H),
6.97 (d, J = 8.5 Hz, 1H), 6.95 (s, 1H), 6.21 (s, 1H), 3.86 (s, 5H), 2.40 (s, 3H).
3.2.6 Synthesis of 7-methoxy-4-methylcoumarin (8). The synthesis of 7-methoxy-4methylcoumarin took place via a mixture of 1.241g of 3-methoxy phenol (1.0 mmol) and 1.304g
of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. white powder; 33.3% yield; m.p. 159160oC (Shirini, Zolfigol, & Albadi, 2010); 1H NMR (301 MHz, DMSO-d6) δ 10.04 (s, 1H), 9.28
(s, 1H), 7.09 (d, J = 8.7 Hz, 1H), 6.81 (d, J = 8.6 Hz, 1H), 6.12 (s, 1H), 2.35 (s, 3H).
3.2.7 Synthesis of 5,7-dihydroxy-4-methylcoumarin (9). The synthesis of 5,7dihydroxy 4-methylcoumarin took place via a mixture of 1.261g of Phloroglucinol (1.0 mmol)
and 1.304g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. Orange powder; 66% yield;
m.p. 280-281oC (Sharma et al., 2005); 1H NMR (301 MHz, DMSO-d6) 1H NMR (301 MHz,
DMSO-d6) δ 10.52 (s, 1H), 10.29 (s, 1H), 6.25 (d, J = 2.3 Hz, 1H), 6.16 (d, J = 2.3 Hz, 1H), 5.84
(d, J = 1.2 Hz, 1H), 2.48 (s, 3H).
3.2.8 Synthesis of 5-hydroxy-4,7-dimethylcoumarin (10). As shown in scheme 10, the
synthesis of 5-hydroxy-4,7-dimethylcoumarin took place via a mixture of 1.065g of orcinol (1.0
mmol) and 1.116g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. white powder; 76%

22
yield m.p. 259-260oC (Y. Wang, Xu, Tian, Li, & Wang, 2009) 1H NMR (301 MHz, DMSO-d6) δ
6.62 (s, 1H), 6.57 (s, 1H), 6.05 (s, 1H), 2.54 (s, 3H), 2.27 (s, 3H).
3.2.9 Synthesis of 7-methoxy-4-methylcoumarin (11). As shown in scheme 11, the
synthesis of 7-methoxy-4-methylcoumarin took place via a mixture of 1.241g of 3-methoxy
phenol (1.0 mmol) and 1.304g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr.Ivory
powder; 40% yield; m.p. 159-160oC (Shirini et al., 2010) 1H NMR (301 MHz, DMSO-d6) δ 6.98
(s, 1H), 6.20 (s, 1H), 3.85 (s, 3H), 2.39 (d, J = 1.3 Hz, 3H).
3.3 Synthesis of Coumarin Derivatives with ZrCl4

Scheme 6. Synthesis of 7,8-dihydroxy-4-methylcoumarin.
3.3.1 Synthesis of 7,8-dihydroxy-4-methylcoumarin (12). Into a 50mL round bottom
flask 1.26g of pyrogallol, 1.30g of ethyl acetoacetate was allowed to react in the presence of
0.233g of ZrCl4. The reaction took place at room temperature and stirred for 10 minutes. After
10 minutes, the reaction mixture was quenched with cold DI water, washed (3x with cold DI
water) and filtered via vacuum filtration. After the filtration, the product was placed into a
storage vial, and placed onto the hot vacuum for drying overnight. Purple powder ; 21% yield;
m.p. 241-243oC (Sharma et al., 2005) 1H NMR (301 MHz, Methanol-d4) δ 4.82 – 0.93 (m, 1H).
3.3.2 Synthesis of 7-hydroxy-4-methylcoumarin (13). (1.10g) of Resorcinol, (1.30g)
ethyl acetoacetate, (0.145g) ZrCl4. White powder ; 35% yield. m.p. 184oC (Sharma et al., 2005)
1

H NMR (400 MHz, DMSO-d6) δ 9.56 (s, 1H), 7.05 (d, J = 8.5 Hz, 1H), 6.46 (d, J = 2.5 Hz, 1H),

6.20 (s, 1H), 1.64 (s, 3H).
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3.3.3 Synthesis of 5-hydroxy-4,7-dimethylcoumarin (14). (1.24g) of Orcinol, (1.30g)
ethyl acetoacetate, (0.232g) ZrCl4. 13% yield; m.p.259-260oC (Sharma et al., 2005); 1H NMR
(301 MHz, DMSO-d6) δ 10.54 (s, 1H), 6.62 (s, 1H), 6.56 (s, 1H), 6.06 (s, 1H), 2.28 (s, 3H), 2.09
(s, 3H).
3.3.4 Synthesis of 6-chloro-7-hydroxy-4-methylcoumarin (15). (2.89g) of 4-chloro
resorcinol, (2.60g) ethyl acetoacetate, (0.931g) ZrCl4. Beige solid; 11% yield; m.p. 278-280oC
(Chakravarti & Ghosh, 1935) 1H NMR (301 MHz, Pyridine-d5) δ 9.03 (s, 1H), 7.96 (d, J = 42.4
Hz, 1H), 7.52 (s, 1H), 6.49 (s, 1H).
3.3.5 Synthesis of 7-hydroxy-4-methylcoumarin (16). (1.10g) of Resorcinol, (1.30g)
ethyl acetoacetate, (0.145g) ZrCl4. Purple crystals; 68% yield; m.p. 184oC (Sharma et al., 2005);
1

H NMR (301 MHz, DMSO-d6) δ 10.52 (s, 1H), 7.65 – 7.53 (m, 1H), 6.70 (t, J = 1.8 Hz, 1H),

6.11 (d, J = 1.8 Hz, 1H), 2.43 – 2.28 (m, 3H).
3.4 Synthesis of TBDMS Coumarin Derivatives
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Scheme 7. Synthesis of 7-TBDMS-4,8-dimethylcoumarin.
3.4.1 Synthesis of 7-tbdms-4,8-dimethylcoumarin (17). A solution of 7-hydroxy-4,8dimethylcoumarin (0.5g, 1.0eq) was treated with TBDMSCl (1.1eq) and Et3N (1.0eq) in THF
(20mL).The reaction was stirred at room temperature until the starting material was no longer in
solution (~18hrs). The reaction was monitored via TLC to determine if the reaction was
complete. The reaction was quenched with H2O (40mL) and extracted with ethyl acetate (3x
15mL). The organic layers were combined and washed with H2O (2x 20mL), and dried with
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Na2SO4. The product was filtered and concentrated under vacuum to give a residue that was
purified by silica gel column chromatography eluting with 20% ethyl acetate/n-hexane (v/v).
white powder; 68% yield; 1H NMR (301 MHz, DMSO-d6) δ 10.47 (dd, J = 15.8, 9.1 Hz, 3H),
7.62 – 7.42 (m, 3H), 6.90 (q, J = 8.6, 7.5 Hz, 3H), 6.29 – 6.09 (m, 3H), 5.44 – 5.23 (m, 2H), 3.61
– 3.41 (m, 7H), 3.02 (s, 1H), 2.96 – 2.76 (m, 1H), 2.62 (s, 3H), 2.45 – 2.34 (m, 8H), 2.31 – 2.12
(m, 9H), 1.11 – 0.81 (m, 29H), 0.21 – 0.04 (m, 2H).
3.4.2 Synthesis of 5,7-(tbdms)2-4-methylcoumarin (18). 5,7-dihydroxy-4methylcoumarin 0.808g, (1.0eq) was treated with 0.696g TBDMSCl (1.1eq) and 0.425g Et3N
(1.0eq) in THF (20mL).The reaction was stirred at room temperature until the starting material
was no longer in solution (~18hrs). Ivory powder; 21% yield 1H NMR (301 MHz, DMSO-d6) δ
6.23 (s, 1H), 6.14 (s, 1H), 5.83 (s, 1H), 1.21 (s, 2H).
3.4.3 Synthesis of 5-tbdms-4,7-dimethylcoumarin (19). 5-hydroxy-4,7dimethylcoumarin 0.752g, (1.0eq) was treated with TBDMSCl 0.447g (1.1eq) and 0.274g Et3N
(1.0eq) in THF (20mL).The reaction was stirred at room temperature until the starting material
was no longer in solution (~18hrs). 0.31% yield; 1H NMR (301 MHz, Acetonitrile-d3) δ 6.67 (s,
1H), 6.56 (s, 1H), 5.98 (d, J = 1.5 Hz, 1H), 2.56 (d, J = 6.4 Hz, 3H), 2.32 (d, J = 6.0 Hz, 3H),
1.00 (d, J = 1.4 Hz, 2H), 0.36 (s, 1H).
3.4.4 Synthesis of 6-n-dodecyl-7-tbdms-4-methylcoumarin (20). 6-n-dodecyl- 7hydroxy-4-methylcoumarin 2.0g, (1.0eq) was treated with 0.965g TBDMSCl (1.1eq) and 0.370g
Et3N (1.0eq) in THF (25mL).The reaction was stirred at room temperature until the starting
material was no longer in solution (~18hrs). Tan solid; 47% yield; 1H NMR (301 MHz, DMSOd6) δ 7.41 (s, 1H), 6.74 (d, J = 13.2 Hz, 1H), 6.09 (s, 1H), 2.37 (d, J = 7.9 Hz, 3H), 1.53 (s, 3H),
1.25 (d, J = 13.5 Hz, 19H), 0.99 (s, 2H), 0.94 – 0.71 (m, 5H), 0.28 (s, 1H), -0.05 (s, 1H).
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3.4.5 Synthesis of 7,8-(tbdms)2-4-methylcoumarin (21). 7,8-dihydroxy-4methylcoumarin 1.980g (1.0eq) was treated with TBDMSCl (1.1eq) and 1.016g Et3N (1.0eq) in
THF (20mL).The reaction was stirred at room temperature until the starting material was no
longer in solution (~18hrs). White powder; 15% yield; 1H NMR (301 MHz, DMSO-d6) δ 6.91 (d,
J = 8.5 Hz, 1H), 6.63 (d, J = 8.4 Hz, 1H), 5.95 (s, 2H), 2.33 (s, 3H), 2.18 (s, 6H), 0.84 (s, 6H).
3.5 Synthesis of 2H-Chromene-2-Thione Derivatives

Scheme 8. Synthesis of 7-hydroxy-4-methyl-2H-chromene-2-thione.
3.5.1 Synthesis of 7-hydroxy-4-methyl-2h-chromene-2-thione (3a). As shown in
scheme 12, the synthesis of 7-hydroxy-4-methyl-2H-chromene-2-thione will take place via a
mixture of 7-methoxy-4-methylcoumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol)
refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 hours. After the
reflux, the reaction mixture was evaporated under reduced pressure to collect the product. The
solid product was re-crystallized from methanol to give 7-hydroxy-4-methyl-2H-chromene-2thione. Brown solid crystals. 11% yield. 1H NMR (400 MHz, DMSO-d6) δ 10.89 (s, 1H), 7.72 (s,
1H), 7.06 (s, 1H), 6.93 (s, 1H), 6.88 (s, 1H), 2.35 (s, 3H). IR (KBr): ν 3183, 2366, 1619, 1595,
1546, 1443, 1397, 1304, 1265, 1215, 1156, 1099, 1070 cm -1
3.5.2 Synthesis of 7-hydroxy-4,8-dimethyl-2h-chromene-2-thione (4a). The synthesis
of 7-hydroxy-4,8-dimethyl-2H-chromene-2-thione will take place via a mixture of 7-hydroxy-4,8
dimethylcoumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol) refluxed in ~30mL (less in
some cases) of hot anhydrous (dry) toluene for 3 hours. Dark green solid; 54% yield; m.p. 205oC
1

H NMR (400 MHz, Acetonitrile-d3) δ 7.67 (dt, J = 8.7, 0.4 Hz, 1H), 7.30 – 6.60 (m, 3H), 3.89
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(s, 3H), 2.33 (d, J = 1.1 Hz, 4H). 13C NMR (101 MHz, cd3cn) δ 197.56, 163.24, 157.82, 146.33,
126.05, 115.20, 113.72, 100.36, 55.88, 29.90, 17.18. IR (KBr): ν 1632, 1599, 1546, 1513, 1447,
1387, 1298, 1245, 1208, 1149, 1096 cm-1
3.5.3 Synthesis of 7-tbdms-4,8-dimethyl-2h-chromene-2-thione (4b). The synthesis of
Synthesis of 7-tertbutyldimethylsilyloxy-4,8-dimethyl-2H-chromene-2-Thione will take place
via a mixture of 7-tertbutyldimethylsilyloxy-4,8-dimethylcoumarin (5.0 mmol) and Lawesson’s
Reagent (6.0 mmol) refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3
hours. Yellow powder; 33% yield; m.p. 243oC; 1H NMR (301 MHz, DMSO-d6) δ 7.59 (dd, J =
13.8, 6.6 Hz, 1H), 7.21 (d, J = 21.9 Hz, 1H), 6.99 (s, 1H), 2.43 – 2.02 (m, 3H), 0.85 (d, J = 6.7
Hz, 1H), 0.13 (s, 1H), -0.05 (s, 1H). IR (KBr): ν 1615, 1595, 1556, 1500, 1443, 1387, 1278,
1156, 1106, 1020, 755 cm -1
3.5.4 Synthesis of 6-chloro-7-hydroxy-4-methyl-2h-chromene-2-thione (5a). The
synthesis of 6-chloro-7-hydroxy-4-methyl-2H-chromene-2-thione will take place via a mixture
of 6-chloro-7-hydroxy-4-methylcoumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol)
refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 hours. An azeotrope
was done using ethanol to remove the solvent from the reaction mixture. Brown powder. 46%
yield. m.p. 243oC; 1H NMR (400 MHz, Acetonitrile-d3) δ 7.67 (s, 1H), 7.00 (s, 1H), 6.56 (s, 0H),
5.01 (s, 3H). 13C NMR (101 MHz, CD3CN) δ 197.02, 157.76, 155.88, 144.23, 127.12, 113.81,
112.07, 108.66, 55.12, 22.38.
3.5.5 Synthesis of 6-n-dodecyl-7-hydroxy-4-methyl-2h-chromene-2-thione (6a). As
shown in scheme 14, the synthesis of 6-n-dodecyl-7-hydroxy-4-methyl-2H-chromene-2-thione
will take place via a mixture of 6-n-dodecyl-7-hydroxy-4-methylcoumarin (5.0 mmol) and
Lawesson’s reagent (6.0 mmol) refluxed in ~30mL (less in some cases) of hot anhydrous (dry)
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toluene for 3 hours. Yellow powder 31% yield; m.p. 299oC; 1H NMR (400 MHz, Chloroform-d)
δ 7.55 (s, 1H), 7.03 (t, J = 1.1 Hz, 1H), 6.90 (s, 1H), 2.63 – 2.56 (m, 2H), 2.36 (d, J = 1.1 Hz,
3H), 1.34 – 1.18 (m, 16H), 0.90 – 0.81 (m, 3H). 13C NMR (101 MHz, cdcl3) δ 197.25, 158.62,
156.35, 128.92, 125.99, 125.27, 115.01, 111.69, 102.54, 31.90, 30.93, 29.99, 29.65, 29.62, 29.59,
29.48, 29.47, 29.33, 22.67, 18.20, 14.10. IR (KBr): ν 2915, 1625, 1559, 1390, 1265, 1215 cm -1
3.5.6 Synthesis of 7,8-dihydroxy-4-methyl-2h-chromene-2-thione (7a). As shown in
scheme 15, the synthesis of 7,8-dihydroxy-4-methyl-2H-chromene-2-thione thiocoumarin will
take place via a mixture of 7,8-dihydroxy-4-methylcoumarin (5.0 mmol) and Lawesson’s
Reagent (6.0 mmol) refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3
hours. Yellow solid; 21% yield; m.p. 230-235oC 1H NMR (DMSO-d6 + CDCl3, 300 MHz): d
2.34 (3H, s, CH3), 6.95 (1H, d, J = 8.6Hz, C-6H), 7.02 (1H, s, C-3H), 7.09 (1H, d, J = 8.6 Hz, C5H), 8.83 and 8.94 (2H, 2s, 1H each, 2 · OH); 13C NMR (DMSOd6+ CDCl3, 75.5 MHz): d 20.68
(CH3), 116.42 (C-6), 117.72 (C-10), 118.07 (C-5), 118.31 (C-3), 134.23 (C-4), 148.55 and
148.93 (C-7 and C-8), 151.96 (C-9) and 199.31 (C-2). IR (KBr): 3312 (OH), 2925, 2855, 1561,
1434, 1366, 1254 and 1095 cm-1 (Kumar et al., 2005)
3.5.7 Synthesis of 7-methoxy-4-methyl-2h-chromene-2-thione (8a). As shown in
scheme 16, the synthesis of 7-methoxy-4-methyl-2H-chromene-2-thione will take place via a
mixture of 7-methoxy-4-methyl coumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol)
refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 hours. An azeotrope
was done using hexanes to extract the product from the reaction mixture. Brown crystals; 61%
yield; m.p. 183oC; 1H NMR (400 MHz, Acetonitrile-d3) δ 7.74 – 7.63 (m, 1H), 7.04 (q, J = 1.1
Hz, 1H), 7.02 (d, J = 0.4 Hz, 0H), 7.01 (d, J = 2.5 Hz, 0H), 6.99 (d, J = 2.5 Hz, 0H), 3.90 (s, 3H),
2.34 (d, J = 1.1 Hz, 3H), 2.09 (s, 3H). 13C NMR (101 MHz, cd3cn) δ 202.17, 197.60, 163.26,
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157.85, 146.36, 126.28, 115.22, 113.73, 100.38, 55.89, 17.17. IR (KBr): ν 1625, 1599, 1546,
1443, 1387, 1294, 1245, 1208, 1146, 1070, 841 cm-1
3.5.8 Synthesis of 5,7-dihydroxy-4-methyl-2h-chromene-2-thione (9a). As seen in
scheme 17, the synthesis of 5,7-dihydroxy-4-methyl-2H-chromene-2-thione will take place via a
mixture of 5,7-dihydroxy-4-methyl coumarin (5.0 mmol) and Lawesson’s reagent (6.0 mmol)
refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 hours. 1H NMR
(400 MHz, Acetonitrile-d3) δ 7.84 – 7.61 (m, 1H), 7.10 – 6.94 (m, 1H), 5.63 (s, 1H). 13C NMR
(101 MHz, cd3cn) δ 206.66, 162.71, 160.37, 157.24, 156.91, 133.08, 132.42, 113.65, 109.85,
23.00.
3.5.9 Synthesis of 5-hydroxy-4,7-dimethyl-2h-chromene-2-thione (10a). The synthesis
of 5-hydroxy-4,7-dimethyl-2H-chromene-2-thione will take place via a mixture of 6-chloro-7
hydroxy-4-methyl coumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol) refluxed in ~30mL
(less in some cases) of hot anhydrous (dry) toluene for 3 hours. Brown solid; 13% yield; m.p.
249-250oC; 1H NMR (400 MHz, Chloroform-d) δ 7.47 (d, J = 38.5 Hz, 1H), 6.78 (s, 1H), 6.64
(s, 1H), 6.47 (s, 1H), 2.13 (s, 3H). 13C NMR (101 MHz, cdcl3) δ 200.96, 162.49, 161.98, 153.01,
149.10, 131.62, 113.82, 112.74, 27.94, 26.46. IR (KBr): ν 1625, 1586, 1539, 1506, 1443, 1278,
1338, 1156, 1132, 828 cm-1

29
CHAPTER 4
Results and Discussion
4.1 Discussion
To improve the effectiveness of coumarin as a therapeutic compound for the treatment of
cancer, a sulfur atom was substituted at the 2 position on the coumarin. To increase the potency
of the compound (meaning to increase the compounds ability to enhance the activity of
mechanisms already within the body) a sulfur atom was substituted for this reason also. Each
coumarin and 2H-chromene-2-thione derivatives were synthesized successfully. To determine if
indeed the coumarin and 2H-chromene-2-thione derivatives were synthesized, the NMR
instrument was used to characterize each compound synthesized.

Scheme 9. Mechanism of Von Pechmann condensation.
4.1.1 Mechanism of the von pechmann condensation. The Von Pechmann
condensation takes place via the condensation of a β-keto ester and a phenol. Derivatives of
Resorcinol were utilized as the phenol in this research. A strong Brøsted-Lowry Acid or a Lewis
Acid is required to provide the acidic conditions to carry out the transformation of the coumarin
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derivatives. Scheme 8 illustrates the mechanism for the coumarin formation. The reaction
proceeds via the transesterification and keto-enol tautomerisation of the resorcinol and ethyl
aceto acetate. A Michael 1,4 addition will take place to lay the frame work for the coumarin
structure. The Michael addition takes place via a conjugate 1, 4 addition of a resonance stabilized
carbanion (which is the Michael donor) to an activated α,β-unsaturated compound (Michael
acceptor) (William H. Brown, 2005). The carbon-carbon double bond situated at the four
position is the Michael acceptor. Rearomatisation follows the Michael addition and a loss of
water gives the coumarin structure.
4.1.2 Comparison of lewis acid catalysts. The Von Pechmann condensation utilized in
this research used green chemistry via a one pot synthesis that required no solvent. No solvent is
required for the reaction to take place however, ethyl aceto acetate is a liquid reagent which
creates a homogenous mixture with the catalyst and resorcinol and the reaction can proceed as
followed. In this particular research, InCl3 was chosen as the Lewis Acid to carry out the
formation of the coumarin derivatives due to its effectiveness as a catalyst, obtaining the
coumarin derivatives in 80-90% percent yields. InCl3 although an excellent catalyst for the Von
Pechmann condensation it is expensive selling at $75 for 10g of the catalyst. ZrCl4, however is
inexpensive selling at $39 for 10g. In this research, strategies to efficiently synthesize the
coumarin derivatives were investigated. To allow for a more green synthesis of the coumarin
derivatives ZrCl4 was explored as a the Lewis Acid in the Von Pechmann reaction as it has
proven capability to effectively carry out the transformation of coumarin derivatives in a solvent
free ten minute reaction at room temperature (Sharma et al., 2005). For this reason, another set of
coumarin derivatives in the research utilized ZrCl4 as the catalyst. Table 1 displays the coumarin
derivatives synthesized utilizing InCl3 and ZrCl4 as the catalyst.
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Table 2
Percent yields of InCl3 and ZrCl4 Catalyzed procedure

Compound

InCl3 Percent
Yield (%)

ZrCl4 Percent Yield
(%)

80

68

84

___

13

11

85

___

46

21

33

___

66

___

76

13

Shown in table are the percent yields obtained for the respective coumarin derivatives
synthesized. The coumarin derivatives synthesized using InCl3 that contain hydroxyl substituents
all had semi relatively high yields (with the exception of 7,8-dihydroxy-4-methylcoumarin in
46% percent yield). The 6-chloro-7-hydroxy-4-methylcoumarin resulted in a very low yield; this
could possibly be due to the solubility of the reagent 4-chloro resorcinol. Table 2 also shows the
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percent yields of the coumarins obtained via the ZrCl4 procedure. Although the yields were fair,
from the NMR spectra it proved that several coumarin derivatives were not synthesized, due to
impurities within the spectra. For the coumarin derivative 7,8-dihydroxy-4-methylcoumarin a
suitable NMR solvent could not be obtained to perform NMR analysis. Both DMSO and CH2Cl2
were utilized as the solvent for NMR analysis of the compound but attempts were unsuccessful.
It was proposed that possibly the hydroxyl groups being adjacent to each other chelated with the
Zirconium in ZrCl4.
4.2 Discussion of TBDMS Coumarin Derivatives
4.2.1 Tertbutyldimethylsilyloxy (tbdms) coumarin derivatives. One method of
synthesizing the 2H-chromene-2-thione derivatives successfully involved a protection step of the
hydroxyl substituents attached to the coumarin atom using t-butyldimethylchlorosilane, triethyl
amine in THF, to minimize the reactivity of the oxygen atoms. The percent yields of the
protected coumarin derivatives range from 68%-15% respectively. Table 3 shows the
experimental results obtained from the protection of the hydroxyl substituents on the coumarin
molecules. The trend shown in the table is the coumarin derivatives that contained multiple
hydroxyl substituents had lower percent yields than the coumarin derivatives that contained only
one hydroxyl substituent with the exception of 6-n-dodecyl-7-TBDMS-4-methylcoumarin which
obtained the highest percent yield (74%). The 12 carbon chain is, therefore steric hindrance is is
relatively minimized in comparison to branched chain structures. In the 7,8-di-TBDMS-4methylcoumarin, the percent yield is lower due to steric hindrance from the branching of both
substituents that are adjacent to each other. The percent yield of 5-TBDMS-4,7dimethylcoumarin was extremely low due insoluble precipitate formation during the work up
steps to obtain the coumarin derivative.
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Table 3
Percent Yields of the Protected Coumarins

Compounds

Percent Yields (%)
68

21

0.31

74

15
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Figure 6. Expected NMR chemical shifts.
4.3 Expected Coumarin NMR Spectra
For the 1H NMR spectra of the coumarin derivatives a singlet peak around 2.3 ppm is
expected. This is indicative of methyl protons bound to the allylic carbon on the coumarin
molecule. This is a key characteristic of the 4 substituted coumarin derivatives synthesized in
this research. In the aromatic region of the 1H NMR spectra two sets of doublets and two singlet
peaks are expected from the 1H NMR spectra. The protons responsible for these chemical shifts
are the adjacent protons on the aromatic ring (Carbon 5 and 6 in figure 5) and the hydrogen
attached to the carbon at the eighth position on the aromatic ring (carbon 8 in figure 5). The
vinylic hydrogen (carbon 3 in figure 5) is responsible for the other singlet peak at 6.1ppm. Since
various resorcinol’s were used in the formation of the coumarins also, it is expected that there
will be hydroxyl peaks in the NMR spectra around 10.0-11.0 ppm.
4.3.1 Expected thione spectra. With the 2H-chromene-2-thione derivatives, similar
spectra to the coumarin derivatives is expected for these derivatives as well. However, there will
be a chemical shift in the protons of the 2H-chromene-2-thione derivatives due to the sulfur atom
attachment. From the variance in the 1H and 13C NMR Spectra of coumarin and the 2H-
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chromene-2-thione derivatives, it will be determined if the 2H-chromen-2-thione derivatives
were synthesized.

Figure 7. 1H NMR spectra of 7-hydroxy-4-methylcoumarin.
4.3.2 Discussion of the 7-hydroxy-4-methylcoumarin spectra. The formation of
coumarin (3) is shown in scheme 3. This reaction took place via the Von Pechmann condensation
of equimolar amounts of ethyl aceto acetate and resorcinol. Figure 6 represents the NMR spectra
obtained from 7-hydroxy 4-methylcoumarin. The coumarin was obtained in 80% yield. From the
1

H NMR spectra it shows that the desired coumarin was indeed synthesized. In the aromatic

region, there are two sets of doublet peaks at 6.74ppm and 7.57ppm indicative of the neighboring
hydrogen’s on the aromatic ring. Also in the aromatic region there is a singlet peak at 6.11δ
which is the chemical shift for the proton on the aromatic ring at the eighth carbon position
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(shown in figure 5). The chemical shift at 10.5δ is the hydroxyl proton. The singlet peak at 6.0 is
the chemical shift of the vinylic proton (the hydrogen attached to the alkene carbon). This proton
is expected to undergo the most change of all the protons on the coumarin molecule due to the
proton being adjacent to the sulfur atom in the thione derivatives.

Figure 8. 1H NMR spectra of the aromatic region of 7-hydroxy-4-methylcoumarin.
Also in the aromatic region as shown in figure 8, there is a singlet peak at 6.11δ which is
the chemical shift for the proton on the aromatic ring at the eighth carbon position (shown in
figure 5). The chemical shift at 10.5ppm is the hydroxyl proton.
The singlet peak at 6.0 is the chemical shift of the vinylic proton (the hydrogen attached
to the alkene carbon). These protons are known to have a shift in this region. It is only when they
are attached/adjacent to an electronegative atom that they experience a chemical shift. Therefore,
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the vinylic proton is expected to undergo the most change of all the protons on the coumarin
molecule due to the proton being adjacent to the sulfur atom in the thione derivatives.

Figure 9. 1H NMR spectra of the allylic hydrogen chemical shift of 7-hydroxy-4methylcoumarin.
The methyl protons attached to the allylic carbon have a chemical shift at 2.34ppm. This
chemical at 2.34ppm will be a singlet peak due to no neighboring hydrogens adjacent to the
allylic protons. Also, the allylic proton shift is a key characteristic in the compounds synthesized
in the research due to ethyl acetoacetate being the β-keto ester utilized in this research. If another
β-keto ester derivative where used, there would be a difference in spectra due to a different atom
being attached at the alkene position. The NMR solvent that was used for the NMR analysis was
DMSO, which is responsible for the chemical shifts at 2.5ppm. The broad chemical shifts at
3.3ppm represent waters of hydration.
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Figure 10. 1H NMR spectra of 7-hydroxy-4-methyl-2H-chromene-2-thione.
4.3.3 Discussion of the thione spectra. As seen in the NMR spectra of 7 hydroxy-4methyl 2H-chromene-2-thione, there is a change in the chemical shifts. The allylic and phenolic
chemical shifts in the 1H NMR of the thione derivative did not vary much from the 1H NMR
spectra of the coumarin derivative. The chemical shift that underwent the most change was the
vinylic hydrogen as it has shifted from 6.0-6.1ppm where it comes in on the coumarin molecule
to 7.0-7.05ppm in the 1H NMR of the 2H-chromene-2-thione derivative. This indicates that the
sulfur atom being substituted at the carbonyl, has affected this proton shift. However, in order to
validate this claim, 13C and infrared spectroscopy will be the determining factors for the
prescence of the C=S bond, and the absence of the carbonyl stretch in the infrared spectra.
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Figure 11. Aromatic region of the 1H NMR spectra of 7-hydroxy-4-methyl-2H-chromene-2thione.
Figure 11 is the aromatic region of the NMR spectra. The aromatic hydrogens of the
coumarins typically have a chemical shift around 7.0-8.0ppm, however in the chromene-2-thione
derivative; it appears that the aromatic and vinylic hydrogen’s have switched chemical shifts.
This may possibly be due to the sulfur atom at the 2-one position.
There are three sets of doublets and two singlets. The pairs of doublets in the aromatic
region of the 1H NMR spectrum indicates that the hydrogen’s adjacent to each other on the
aromatic ring are coupling each other. However from the J coupling value proved that this was
inconclusive as no J coupling value was calculated for both hydrogens (see experimental 3.5.1).
The doublet at 6.8ppm is from the lone hydrogen that has no neighboring hydrogen’s. It is
possible that the hydrogen is being coupled as well via “W” coupling. In order to determine that
this is occurring, there is to be observed a J coupling value of 2-3 Hz. The “W’ coupling theory
would prove to be inconclusive as no J coupling value was obtained for the aromatic hydrogen.
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Figure 12. 1H NMR spectra of the allylic hydrogen chemical shift.
Figure 11 is the aromatic region of the NMR spectra. There are three sets of doublets and
two singlets. The pairs of doublets in the aromatic region of the 1H NMR spectrum indicates that
the hydrogen’s adjacent to each other on the aromatic ring are coupling each other. The lone
hydrogen that has no neighboring hydrogen’s is being coupled as well via “W” coupling. The
aromatic hydrogens of the coumarins typically have a chemical shift around 7.0-8.0ppm,
however in the chromene-2-thione derivative; it appears that the aromatic and vinylic hydrogen’s
have switched chemical shifts.
Figure 12 illustrates the region of the spectra that is called the “up field” indicative of the
shielding of hydrogens. The vinylic protons on the coumarin molecule have a shift in this region
typically around 2.3ppm from the three methyl protons. This peak always shows up as a singlet
in this region, however as shown in Figure 9, there is a doublet indicating that the vinylic
hydrogen is coupling with other hydrogens on the chromene-2-thione molecule. Table 4 shows
the variance in the chemical shifts of the vinlyic, allylic, and phenolic protons in the 1H NMR
spectra. From the data table it is seen that there isn’t much change in each chemical shift of the
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coumarin derivatives, possibly a few points difference. However, in the 2H-chromene-2-thione
derivatives, there is a drastic change in the chemical shifts particularly the vinylic hydrogen,
shifting from 6.0ppm to approximately 7.0-7.1ppm and in some cases the phenolic chemical
shifts (at 10-10.8ppm). The allylic protons on both the coumarin and 2H-chromene-2-thione
derivative underwent the least amount of change as it didn’t experience a change in chemical
shift in the thione derivative or the coumarin. From the change in the chemical shifts of vinylic
protons one can possibly conclude that the carbonyl molecule was transformed into its thio
analog. 13C NMR and infrared spectroscopy will be the ultimate factor to determine if the thione
derivative was synthesized.
Table 4
Vinylic, Allylic and Phenolic 1H Chemical Shifts
Compound

Vinyllic 1H
shift (ppm)

Allylic 1H
Shift
(ppm)

Phenolic 1H Shift
(ppm)

O = 6.10
S = 7.02

O = 2.35
S = 2.35

O = 10.52
S = 12.39

O = 6.12
S = 8.05

O = 2.15
S = 2.33

O = 10.41

O = 6.08
S = 7.08

O = 2.34
S = 5.62

O = 10.46
S = 11.76

O = 6.20
S = 7.09

O = 2.38
S = 2.34

O = 7.70, 7.68
S = 8.83; 8.94

O = 6.10
S = 7.23

O = 2.33
S = 2.09
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4.3.4 Discussion of the carbon 13 spectra of coumarin. As stated previously, to
determine if the thio analogs have successfully been synthesized, the determining factor will be
the 13C NMR spectra. According to the referenced literature (indicated by the asterisk in the
table) for the allylic, vinylic, and carbonyl chemical shifts will fall within range of 18-24, 110112 and 155-162ppm (Karimi & Zareyee, 2008). Table 5 provides a quantitative analysis of the
chemical shifts of the various carbons on the coumarin molecule and the environments they are
in. The allylic, vinylic, and carbonyl shifts of the coumarin were compared to the thio analogs.
As seen from the table there wasn’t a drastic change in the allylic, and vinylic carbons of the
coumarin molecule and thio derivatives. However, the chemical shift of the carbonyl carbon has
shifted downfield in most of the thio derivatives (with the exception of 6-chloro 7-hydroxy 4methyl 2H-chromene-2-thione) from approximately 160ppm to 197 and further downfield at
206ppm in some thio derivatives. However, the chemical shift of the carbonyl carbon has shifted
downfield in most of the thio derivatives (with the exception of 6-chloro 7-hydroxy 4-methyl
2H-chromene-2-thione) from approximately 160ppm to 197 and further downfield at 206ppm in
some thio derivatives.
When compared to referenced literature for the thio analogs, spectral data of the thio
analogs synthesized in this research correlate to the chemical shifts of the new carbon-sulfur
double bond that is formed during the transformation of the coumarin derivatives. From the
experimental analysis of S. Kumar, B. Singh, and N. Kalra et al. the carbon-sulfur double bond is
expected to fall within the range of 195-200ppm respectively (Kumar et al., 2005). Table 5
shows the chemical shifts of the thio derivatives all have a carbonyl shift of approximately 195200ppm; whereas in the coumarin derivatives the chemical shift was 155-162ppm. With this
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significant change in the chemical shift of the carbonyl carbon the conclusion can be drawn that
the 2H-chromene-2-thione derivatives were successfully synthesized.
From the 13C spectra of 6-chloro-7-hydroxy 4-methylcoumarin it seemed as though the
transformation of the coumarin derivative into the 2H-chromene-2-thione derivative did not take
place due to the chemical shift of the carbonyl carbon (157.76ppm) compared to the coumarin
carbonyl shift of 160.8ppm. This could revert back to the factor of the solubility of the reagent 4chloro resorcinol. Infrared spectroscopy would validate this statement with the absence of the
C=S band in the spectra.
Table 5
Vinylic, Allylic and Carbonyl Carbon 13C Chemical Shifts
Compound

Allylic 13C
shift (ppm)

Vinylic 13C Shift
(ppm)

Carbonyl 13C
Shift (ppm)

O = 18.48*
S = 19.50

O = 113.24*
S = 105.60

O = 161.56*
S = 195.90

O = 18.57*
S = 17.19

O = 112.36*
S = 100.36

O = 160.83*
S = 197.55

O = 19.40*
S = 20.64

O = 112.50*
S = 112.46

O = 160.80*
S = 157.76

O = 19.40*
S = 22.67

O = 112.50*
S = 102.54

O = 160.80*
S = 197.25
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Table 5
Cont.
Compound

Allylic 13C
shift (ppm)

Vinylic 13C Shift
(ppm)

Carbonyl 13C
Shift (ppm)

O = 18.66*
S = 20.68

O = 112.55*
S = 116.42

O = 160.64*
S = 199.31*

O = 18.58*
S = 17.18

O = 112.55*
S = 100.39

O = 162.81*
S = 206.46

O = 23.87*
S = 26.32

O = 109.25*
S = 154.35

O = 155.41*
S = 206.67

O = 23.70*
S = 26.32

O = 112.50*
S = 112.74

O = 160.8*
S = 200.96

Figure 13. 13C NMR spectra of 7-hydroxy-4,8-dimethylcoumarin (Karimi & Zareyee, 2008).
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Figure 14. 13C NMR spectra of 7-hydroxy-4,8-dimethyl-2H-chromene-2-thione.
4.3.5 Discussion of the thione carbon 13 spectra. To provide an illustration of Table 5,
figure 13 is the 13C spectra of 7-hydroxy-4-methylcoumarin (Karimi & Zareyee, 2008). The
peaks that are of interest in this research are the allylic vinylic and phenolic carbon peaks.
Variance in the chemical shifts of these three peaks of in coumarin and thione derivatives were
observed. The carbonyl carbon on the coumarin molecule is expected to undergo the most
change as a sulfur atom is being substituted for an oxygen atom. Shown in the spectra, the
allylic, vinylic, and carbonyl chemical shifts are 18.57, 110.30 (the alkene carbon closest to the
oxygen atom) and 160.83ppm. Figure 14 is the 13C spectra of 7-hydroxy-4-methyl-2Hchromene-2-thione. As seen in the spectra, the chemical shift of the carbonyl carbon underwent
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the most change shifting from 160.83 to 201.56ppm. From the quantitative analysis shown in
table 5, and the spectral data shown, it has been proven that the 2H-chromene-2-thione
derivatives were synthesized.
Table 6
Variance of the C=S Peaks

Compound

C=S Stretch cm-1
1218 cm-1

1242 cm-1

1215 cm-1

1208 cm-1

1238 cm-1

4.4 Discussion of the IR Spectra
4.4.1 Infrared spectra interpretation. In order to validate the 13C NMR spectra of the
thione derivatives, Infrared Spectroscopy was utilized to determine the presence of the C=S
stretch and the absence of the C=O (carbonyl) stretch. The referenced wavelength of the
carbonyl stretch in a pyrone molecule is around 1715 and 1775cm-1 (William H. Brown, 2005).
Two bands are expected in this region. According to NIST (National Institute of Standards and
Technology) chemistry web book for vibrational energy, the C=S stretch is to show up in around
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1275-1030cm-1. The IR spectra of the thione derivatives synthesized in this research shows there
is the absence of the carbonyl stretch around 1715 and 1775 cm-1. Table 6 quantitatively shows
the C=S stretch of the thione derivatives. Each thione derivative within the chart has a stretch
within 1275-1030cm-1; all were closer to the latter end (average wavelength 1225 cm-1).

Figure 15. IR spectra of 7-hydroxy-4-methyl-2H-chromene-2-thione.
Figure 15 illustrates the IR spectra of 7-hydroxy-4-methyl-2H-chromene-2-thione. As
seen, there is a strong peak at 1218 cm-1 which is indicative of the C=S stretch. Also seen in the
IR spectra, there is the absence of peaks in the region for pyrone carbonyls. From the validation
of the IR spectra it has been proven that the thione derivatives were synthesized with success.

48
CHAPTER 5
Discussion and Future Research
From the NMR and IR analysis, it was proven that the 2H-Chromeme-2-Thione
derivatives were indeed synthesized. The key factor in this determination was the vinylic
hydrogen chemical shift in the 1H NMR, the chemical shift of the carbonyl carbon in the 13C
spectra and the absence of the carbonyl stretch in the lactone molecule. As stated, the referenced
shift for the vinylic hydrogen of the coumarin will have a chemical shift of 6.1ppm, for the
carbonyl carbon, a chemical shift of approximately 160ppm in the 13C NMR and the IR stretch
for the carbonyl in the lactone will have 2 bands around 1715 and 1775 cm-1. For each 2Hchromene-2-thione synthesized there was a singlet peak around 7.0-7.1ppm and in the 13C NMR
spectra, there was a chemical shift of approximately 197-200ppm for the carbonyl carbon. For
the IR spectra, there was an absence of the lactone bands and a strong peak around 1225 cm-1 for
wan indication that the C=S bond is present in the molecule. Future recommendations for this
research are to improve upon the synthesis of the 2H-Chromeme-2-Thione derivatives and
increase the percent yields. The protective procedure of the coumarins to be converted into the
2H-chromene-2-thione derivatives seems to be the best strategy to successfully obtain the 2Hchromene-2-thione-derivatives. Although the ZrCl4 catalyzed Von Pechmann condensation
requires no solvent and is carried out at room temperature, to obtain better percent yields and
compounds without impurities heat will be introduced during the reaction to synthesize the
coumarins with ease. Also, other resorcinol derivatives are currently being investigated to be
used in the synthesis of more coumarin derivatives. Recently, 2-Nitro resorcinol was investigated
to determine if the 2H-chromene-2-thione derivative of 2-Nitro resorcinol would make for a
cancer chemopreventive agent of interest. Procedures to synthesize the coumarin derivatives
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containing multiple hydroxyl substituents could also be investigated. Other findings has
concluded that 7,8-dihydroxy-4-methyl-2H-chromene-2-thione derivatives were more potent at
inhibiting TNFα ICAM-1 expression then their respective coumarin analogs. This is said to be
due to the fact that the hydroxyl groups can readily be converted into the quinone form (Kumar
et al., 2005). Therefore synthesizing 2H-chromene-2-thione derivatives with multiple hydroxyl
substituents may provide an excellent candidate as a cancer chemopreventive. The 2Hchromene-2-thione-derivatives synthesized in this study will be sent to the NIH DTP National
Institute of Health Developmental Therapeutics Program to be tested against 60 cancer cell lines
to determine if the thione derivatives inhibit or retard cancer activity in vitro. Optimistically, by
having the thio substituent attached to the coumarin molecule will have a greater effect on the
anticancer activity of the coumarin derivatives.
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Appendix A

Figure. 1H NMR spectra of 7-hydroxy-4,8 –dimethylcoumarin.

Figure 1H NMR spectra of 6-chloro-7-hydroxy-4-methylcoumarin.
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Figure. 1H NMR spectra of 6-n-dodecyl-7-hydroxy-4-methylcoumarin.

Figure. 1H NMR spectra of 7,8-dihydroxy-4-methylcoumarin.
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Figure. 1H NMR spectra of 7-methoxy-4-methylcoumarin.

Figure. 1H NMR spectra of 5,7-dihydroxy-4-methylcoumarin.
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Figure. 1H NMR spectra of 5,7-ditertbutyldimethylsilyloxy-4-methylcoumarin.

Figure. 1H NMR spectra of 5-tertbutyldimethylsilyloxy-4,7-dimethylcoumarin.
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Figure. 1H NMR spectra of 7,8-ditertbutyldimethylsilyloxy-4-methylcoumarin.

Figure. 1H NMR spectra of 5-hydroxy-4,7-dimethylcoumarin.
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Appendix B

Figure. 1H NMR spectra of 7-tertbutyldimethylsilyloxy-4,8-dimethyl-2H-chromene-2-thione.

Figure. 1H NMR spectra of 6-chloro-7-hydroxy-4-methyl-2H-chromene-2-thione.
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Figure. 1H NMR spectra 7-hydroxy-4,8-dimethyl-2H-chromene-2-thione.

Figure. 1H NMR spectra of 5-hydroxy-4,7-dimethyl-2H-chromene-2-thione.
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Figure. 1H NMR spectra of 7,8-dihydroxy-4-methyl-2H-chromene-2-thione.

Figure. 1H NMR spectra of 7-methoxy-4-methyl-2H-chromene-2-thione.
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Figure. 1H NMR spectra of 6-n-dodecyl-7-hydroxy-4-methyl-2H-chromene-2-thione.

Figure.

13

C NMR spectra of 6-chloro-7-hydroxy-4-methyl-2H-chromene-2-thione.
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Figure. 13C NMR spectra of 6-n-dodecyl-7-hydroxy-4-methyl-2H-chromene-2-thione.

Figure. 13C NMR spectra of 5,7-dihydroxy-4-methyl-2H-chromene-2-thione.
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Figure.

13

C NMR spectra of 5-hydroxy-4,7-dimethyl-2H-chromene-2-thione.

Figure.

13

C NMR spectra of 7-methoxy-4-methyl-2H-chromene-2-thione.

65

856.2

3982
3946
3853
3801
3761
3741
3707
3680
3631
3616
3602
3483
3467
3417
3329
3209
2997

0602IR

1416
1336

0.2

405

0.4

1111

-0.2

1281
1240

1651
1576

0

-0.4

-0.6

4000

3500

3000

2500

2000

1500

1000

500

Figure. IR spectra of 6-n-dodecyl-7-hydroxy-4-methyl-2H-chromene-2-thione.
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